Cross over placebo control trial of dilazep in beta-thalassemia/hemoglobin E patients. | Southeast Asian J Trop Med Public Health; 1999 Jun; 30(2): 307-10 | IMSEAR

Main content 1 Search 2 Footer 3

+A A -A High contrast

Cross over placebo control trial of dilazep in beta-thalassemia/hemoglobin E patients.

Opartkiattikul, N; Sukpanichnant, S; Funahara, Y; Sumiyoshi, A; Wanachiwanawin, W; Tatsumi, N; Fucharoen, S.

Southeast Asian J Trop Med Public Health ; 1999 Jun; 30(2): 307-10

Article in En | IMSEAR | ID: sea-32640

Subject(s)

Adolescent; Adult; Blood Transfusion; Cross-Over Studies; Dilazep/therapeutic use; Female; Hemoglobin E; Hemoglobinopathies/drug therapy; Hemoglobins/metabolism; Humans; Male; Vasodilator Agents/therapeutic use; beta-Thalassemia/drug therapy

Search on Google

Full text: 1 Index: IMSEAR Main subject: Vasodilator Agents / Blood Transfusion / Female / Humans / Male / Hemoglobin E / Hemoglobins / Adolescent / Beta-Thalassemia / Cross-Over Studies Type of study: Clinical_trials Language: En Journal: Southeast Asian J Trop Med Public Health Year: 1999 Type: Article

Search on Google

Full text: 1 Index: IMSEAR Main subject: Vasodilator Agents / Blood Transfusion / Female / Humans / Male / Hemoglobin E / Hemoglobins / Adolescent / Beta-Thalassemia / Cross-Over Studies Type of study: Clinical_trials Language: En Journal: Southeast Asian J Trop Med Public Health Year: 1999 Type: Article